Back to top
more

Tandem Diabetes Care (TNDM)

(Delayed Data from NSDQ)

$35.24 USD

35.24
783,779

-0.32 (-0.90%)

Updated Apr 26, 2024 04:00 PM ET

After-Market: $35.24 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value D Growth F Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 37% (94 out of 252)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

Research for TNDM

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

0 items in cart

Tandem Diabetes Care, Inc. [TNDM]

Reports for Purchase

Showing records 141 - 160 ( 239 total )

Company: Tandem Diabetes Care, Inc.

Industry: Medical - Instruments

Record: 141

07/15/2016

Daily Note

Pages: 41

Medical Devices: 2Q16 MedTech Preview: Stable Trends and Healthy Underlying Fundamentals

Provider: WEDBUSH SECURITIES INC.

Price: 100.00

Research Provided by a Third Party

Company: Tandem Diabetes Care, Inc.

Industry: Medical - Instruments

Record: 142

07/10/2016

Industry Report

Pages: 6

Diabetes: Artificial Pancreas Workshop Provides Insights On the Future of the Diabetes Market

Provider: WEDBUSH SECURITIES INC.

Price: 25.00

Research Provided by a Third Party

Company: Tandem Diabetes Care, Inc.

Industry: Medical - Instruments

Record: 143

07/05/2016

Daily Note

Pages: 6

2H:2016 Top Ideas

Provider: Feltl & Company

Price: 25.00

Research Provided by a Third Party

Company: Tandem Diabetes Care, Inc.

Industry: Medical - Instruments

Record: 144

06/15/2016

Daily Note

Pages: 9

American Diabetes Association Meeting Suggests a Diabetes Technology Renaissance Is Coming; Reiterate OUTPERFORM

Provider: WEDBUSH SECURITIES INC.

Price: 25.00

Research Provided by a Third Party

Company: Tandem Diabetes Care, Inc.

Industry: Medical - Instruments

Record: 145

05/19/2016

Industry Report

Pages: 5

J-J Medical Devices Investor Day Takeaways on Robotic Surgery, Diabetes, AFib,Sinus Surgery, Endoscopic Stapling

Provider: WEDBUSH SECURITIES INC.

Price: 10.00

Research Provided by a Third Party

Company: Tandem Diabetes Care, Inc.

Industry: Medical - Instruments

Record: 146

05/16/2016

Industry Report

Pages: 7

MDT/UHC Insulin Pump Agreement Could Become A Significant POSITIVE for the Other

Provider: WEDBUSH SECURITIES INC.

Price: 25.00

Research Provided by a Third Party

Company: Tandem Diabetes Care, Inc.

Industry: Medical - Instruments

Record: 147

05/03/2016

Daily Note

Pages: 9

Volatility in Diabetes Stocks Following UNH/MDT Agreement Creates Buying Opportunity; Reiterate OUTPERFORM on DXCM, PODD, TNDM

Provider: WEDBUSH SECURITIES INC.

Price: 25.00

Research Provided by a Third Party

Company: Tandem Diabetes Care, Inc.

Industry: Medical - Instruments

Record: 148

05/02/2016

Company Report

Pages: 9

Strong performance continues as Q1 beats, guidance raised, reiterate STRONG BUY

Provider: Feltl & Company

Analyst: HAYNOR B

Price: 25.00

Research Provided by a Third Party

Company: Tandem Diabetes Care, Inc.

Industry: Medical - Instruments

Record: 149

04/29/2016

Company Report

Pages: 7

Demand For Tandem''s Insulin Pumps Exceeds Expectations; Reiterate OUTPERFORM

Provider: WEDBUSH SECURITIES INC.

Price: 25.00

Research Provided by a Third Party

Company: Tandem Diabetes Care, Inc.

Industry: Medical - Instruments

Record: 150

04/28/2016

Company Report

Pages: 7

Feltl Insulin Pump Project: Historical survey of ~6,000 users

Provider: Feltl & Company

Analyst: HAYNOR B

Price: 25.00

Research Provided by a Third Party

Company: Tandem Diabetes Care, Inc.

Industry: Medical - Instruments

Record: 151

04/26/2016

Daily Note

Pages: 15

Diabetes 1Q16 Earnings Preview: Despite Seasonally Soft 1Q, Expecting Healthy Trends Driven By New Product Launches

Provider: WEDBUSH SECURITIES INC.

Price: 50.00

Research Provided by a Third Party

Company: Tandem Diabetes Care, Inc.

Industry: Medical - Instruments

Record: 152

04/19/2016

Industry Report

Pages: 7

Medical Devices - Takeaways from J-J''s 1Q16 Results

Provider: WEDBUSH SECURITIES INC.

Price: 25.00

Research Provided by a Third Party

Company: Tandem Diabetes Care, Inc.

Industry: Medical - Instruments

Record: 153

04/19/2016

Daily Note

Pages: 40

1Q16 MedTech Preview: Stable Trends; Prefer the Oversold Names With Solid Fundamentals

Provider: WEDBUSH SECURITIES INC.

Price: 75.00

Research Provided by a Third Party

Company: Tandem Diabetes Care, Inc.

Industry: Medical - Instruments

Record: 154

02/25/2016

Company Report

Pages: 9

Slim with G4 CGM and pipeline bring momentum into 2016, reiterate STRONG BUY

Provider: Feltl & Company

Analyst: HAYNOR B

Price: 25.00

Research Provided by a Third Party

Company: Tandem Diabetes Care, Inc.

Industry: Medical - Instruments

Record: 155

02/24/2016

Company Report

Pages: 8

Q4 2015 Insulin Pump Project: Historical survey of -6,000 users

Provider: Feltl & Company

Analyst: HAYNOR B

Price: 25.00

Research Provided by a Third Party

Company: Tandem Diabetes Care, Inc.

Industry: Medical - Instruments

Record: 156

02/24/2016

Company Report

Pages: 7

Guidance and Margins Much Better Than Expected, Paving a Path Toward Profitability; Reiterate OUTPERFORM

Provider: WEDBUSH SECURITIES INC.

Price: 25.00

Research Provided by a Third Party

Company: Tandem Diabetes Care, Inc.

Industry: Medical - Instruments

Record: 157

02/10/2016

Industry Report

Pages: 9

Survey of Diabetes Educators Very Positive for DXCM''s Growth Outlook; Suggests Recent Concerns Misplaced; Reiterate OUTPERFORM on DXCM

Provider: WEDBUSH SECURITIES INC.

Price: 25.00

Research Provided by a Third Party

Company: Tandem Diabetes Care, Inc.

Industry: Medical - Instruments

Record: 158

01/31/2016

Industry Report

Pages: 11

Proprietary Survey of Diabetes Educators Suggests Patients Prefer Tandem''s Insulin Pumps; Reiterate OUTPERFORM on TNDM shares

Provider: WEDBUSH SECURITIES INC.

Price: 25.00

Research Provided by a Third Party

Company: Tandem Diabetes Care, Inc.

Industry: Medical - Instruments

Record: 159

01/12/2016

Company Report

Pages: 7

Pre-Announces In Line 4Q15 And Initial 2016 Revenue Guidance; Maintain OUTPERFORM

Provider: WEDBUSH SECURITIES INC.

Price: 25.00

Research Provided by a Third Party

Company: Tandem Diabetes Care, Inc.

Industry: Medical - Instruments

Record: 160

01/08/2016

Daily Note

Pages: 24

MedTech 2016 Outlook: Risk/Reward Looks Attractive

Provider: WEDBUSH SECURITIES INC.

Price: 75.00

Research Provided by a Third Party